GlassScriptPhysician profile
Markus J Byron
NPI 1013678010
$4,768.13
in general payments reported to CMS, 2019-2025
39 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $541 · 2023: $2,540 · 2024: $625 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,747 · Travel and Lodging: $1,380 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,746.52 |
| Travel and Lodging | $1,380.31 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,203.72 | 2023-2025 | Urolift |
| Axonics, INC. | $950.09 | 2023-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $278.20 | 2023-2025 | Erleada, Carvykti, Rybrevant |
| Sumitomo Pharma America, INC. | $251.92 | 2024-2025 | Gemtesa |
| Coloplast Corp | $173.02 | 2024-2025 | |
| Boston Scientific Corporation | $140.10 | 2023-2025 | Spaceoar Vue System - 10ml, Ams 700, General - Female Sui |
| Antares Pharma, INC. | $139.88 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Abbvie INC. | $122.70 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $122.24 | 2023 | Prolaris |
| Olympus America INC. | $120.19 | 2024-2025 | Itind System |
| Astellas Pharma US INC | $118.27 | 2022-2024 | Xtandi |
| Procept Biorobotics Corporation | $109.65 | 2025 | |
| Progenics Pharmaceuticals, INC. | $105.08 | 2023-2024 | Pylarify |
| Incyte Corporation | $95.00 | 2022 | |
| Seagen INC. | $93.00 | 2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $81.75 | 2025 | |
| 180 Medical, INC. | $78.17 | 2023-2024 | Gentlecath, Gentlecath Glide |
| Urogen Pharma, INC. | $76.96 | 2025 | |
| Photocure INC | $56.66 | 2023-2024 | Cysview |
| C. R. Bard, INC. & Subsidiaries | $45.06 | 2025 | Personal Catheter Intermittent Catheter |
| Verity Pharmaceuticals INC. | $44.04 | 2025 | Tlando |
| Merck Sharp & Dohme LLC | $40.96 | 2022 | |
| Tersera Therapeutics LLC | $30.50 | 2022 | |
| Genentech USA, INC. | $29.07 | 2022 | |
| Jazz Pharmaceuticals INC. | $28.38 | 2022 | |
| Calyxo, INC. | $23.82 | 2025 | Cvac Aspiration System |
| Cycle Pharmaceuticals INC | $19.57 | 2025 | Venxxiva |
| Karyopharm Therapeutics INC. | $19.53 | 2023 | Xpovio |
| Lundbeck LLC | $19.28 | 2022 | |
| Servier Pharmaceuticals LLC | $16.96 | 2022 | |
| Pfizer INC. | $16.70 | 2022 | |
| Lilly USA, LLC | $16.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.94 | 2022 | |
| Emd Serono, INC. | $15.90 | 2022 | |
| Puma Biotechnology, INC. | $15.81 | 2022 | |
| Celgene Corporation | $15.29 | 2022 | |
| Halozyme INC | $15.03 | 2023 | |
| Argenx US, INC. | $12.06 | 2022 | |
| Laborie Medical Technologies Corp. | $11.16 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markus Byron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.